Search research articles
Contact Us
Filters
Showing results (41-50 of 49) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 49 results.
ACS Applied Materials & Interfaces
|
January 28, 2021
Lipid-Polyglutamate Nanoparticle Vaccine Platform
Dorien Van Lysebetten, Alessio Malfanti, Kim Deswarte, et al.
Angewandte Chemie (International Ed. in English)
|
October 23, 2024
A Fentanyl Hapten-Displaying Lipid Nanoparticle Vaccine that Non-Covalently Encapsulates a TLR7/8 Agonist and T-Helper Epitope Induces Protective Anti-Fentanyl Immunity
Zifu Zhong, Marie H Deventer, Yong Chen, et al.
Science (New York, N.Y.)
|
May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
ACS Nano
|
September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Biorxiv : the Preprint Server for Biology
|
October 27, 2020
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Angewandte Chemie (International Ed. in English)
|
January 19, 2021
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*
Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Journal of the American Chemical Society
|
June 24, 2021
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators
Anne Huppertsberg, Leonard Kaps, Zifu Zhong, et al.
Science Immunology
|
May 12, 2023
LXR signaling controls homeostatic dendritic cell maturation
Victor Bosteels, Sandra Maréchal, Clint De Nolf, et al.
Nature Communications
|
January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling
Steven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 49) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 49 results.
ACS Applied Materials & Interfaces
|
January 28, 2021
Lipid-Polyglutamate Nanoparticle Vaccine Platform
Dorien Van Lysebetten, Alessio Malfanti, Kim Deswarte, et al.
Angewandte Chemie (International Ed. in English)
|
October 23, 2024
A Fentanyl Hapten-Displaying Lipid Nanoparticle Vaccine that Non-Covalently Encapsulates a TLR7/8 Agonist and T-Helper Epitope Induces Protective Anti-Fentanyl Immunity
Zifu Zhong, Marie H Deventer, Yong Chen, et al.
Science (New York, N.Y.)
|
May 25, 2019
Protein crystallization promotes type 2 immunity and is reversible by antibody treatment
Emma K Persson, Kenneth Verstraete, Ines Heyndrickx, et al.
ACS Nano
|
September 27, 2018
Dendritic Cell Targeting mRNA Lipopolyplexes Combine Strong Antitumor T-Cell Immunity with Improved Inflammatory Safety
Kevin Van der Jeught, Stefaan De Koker, Lukasz Bialkowski, et al.
Biorxiv : the Preprint Server for Biology
|
October 27, 2020
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Modified Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine
Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Angewandte Chemie (International Ed. in English)
|
January 19, 2021
Sterilizing Immunity against SARS-CoV-2 Infection in Mice by a Single-Shot and Lipid Amphiphile Imidazoquinoline TLR7/8 Agonist-Adjuvanted Recombinant Spike Protein Vaccine*
Sonia Jangra, Jana De Vrieze, Angela Choi, et al.
Journal of the American Chemical Society
|
June 24, 2021
Squaric Ester-Based, pH-Degradable Nanogels: Modular Nanocarriers for Safe, Systemic Administration of Toll-like Receptor 7/8 Agonistic Immune Modulators
Anne Huppertsberg, Leonard Kaps, Zifu Zhong, et al.
Science Immunology
|
May 12, 2023
LXR signaling controls homeostatic dendritic cell maturation
Victor Bosteels, Sandra Maréchal, Clint De Nolf, et al.
Nature Communications
|
January 8, 2015
ZEB2 drives immature T-cell lymphoblastic leukaemia development via enhanced tumour-initiating potential and IL-7 receptor signalling
Steven Goossens, Enrico Radaelli, Odile Blanchet, et al.
Page
of 5